After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

Kevin Smith, a resident of Clifton Park, is experiencing the benefits of a recently approved Alzheimer's drug, Leqembi, as he ...

A surprising discovery about how brain cells handle sugar could shift how scientists approach dementia and Alzheimer’s ...

Alzheimer's disease (AD) is a common, debilitating neurodegenerative disease affecting about 10% of people over the age of 65 ...

Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also ...

June is Brain and Alzheimer’s Awareness Month — a chance to examine real-world data that links new treatments to changing ...

Researchers at McMaster University, Cleveland Clinic and Case Comprehensive Cancer Center have uncovered how a protein long ...

A once-a-day pill called blarcamesine may slow memory loss and preserve independence—without the scary side effects or ...

Bi-partisan legislation was introduced in the U.S. House of Representatives to get primary care physicians more training on ...

Tulane University researchers created a first-of-its-kind subcellular map of an area of the brain commonly affected by ...

A new Mayo Clinic AI tool detects dementia patterns in brain scans with remarkable precision, potentially transforming early ...